Fluorescent nanoparticle uptake for brain tumor visualization

Neoplasia

Volumn 8, Issue 4, 2006, Pages 302-311

  Tréhin, Rachel ^a   Figueiredo, Jose Luiz ^a   Pittet, Mikael J ^a   Weissleder, Ralph ^a   Josephson, Lee ^a   Mahmood, Umar ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Brain tumor; Fluorescence; MRI; Nanoparticle; Optical imaging

Indexed keywords

GREEN FLUORESCENT PROTEIN; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HOST CELL; IMMUNE RESPONSE; MACROPHAGE; MALE; METASTASIS; MICROGLIA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; TUMOR CELL; TUMOR MODEL;

EID: 33646400546     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.05751     Document Type: Article

References (41)

1. Winger MJ, Macdonald DR, and Cairncross JG (1989). Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71, 487-493.
2. Bucci MK, Maity A, Janss AJ, Belasco JB, Fisher MJ, Tochner ZA, Rorke L, Sutton LN, Phillips PC, and Shu HK (2004). Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging era. Cancer 101, 817-824.
3. Moore GE (1947). Fluorescein as an agent in the differentiation of normal and malignant tissues. Science 106, 130-131.
4. Haglund MM, Hochman DW, Spence AM, and Berger MS (1994). Enhanced optical imaging of rat gliomas and tumor margins. Neurosurgery 35, 930-940 (discussion 940-931).
5. Haglund MM, Berger MS, and Hochman DW (1996). Enhanced optical imaging of human gliomas and tumor margins. Neurosurgery 38, 308-317.
6. Kircher MF, Mahmood U, King RS, Weissleder R, and Josephson L (2003). A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 63, 8122-8125.
7. Varallyay P, Nesbit G, Muldoon LL, Nixon RR, Delashaw J, Cohen JI, Petrillo A, Rink D, and Neuwelt EA (2002). Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. AJNR Am J Neuroradiol 23, 510-519.
8. McLachlan SJ, Morris MR, Lucas MA, Fisco RA, Eakins MN, Fowler DR, Scheetz RB, and Olukotun AY (1994). Phase I clinical evaluation of a new iron oxide MR contrast agent. J Magn Reson Imaging 4, 301-307.
9. Wunderbaldinger P, Josephson L, Bremer C, Moore A, and Weissleder R (2002). Detection of lymph node metastases by contrast-enhanced MRI in an experimental model. Magn Reson Med 47, 292-297.
10. Saleh A, Schroeter M, Jonkmanns C, Hartung HP, Modder U, and Jander S (2004). In vivo MRI of brain inflammation in human ischaemic stroke. Brain 127, 1670-1677.
11. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, and Lewis J (1989). Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 152, 167-173.
12. Weissleder R and Ntziachristos V (2003). Shedding light onto live molecular targets. Nat Med 9, 123-128.
13. Funovics MA, Weissleder R, and Mahmood U (2004). Catheter-based in vivo imaging of enzyme activity and gene expression: feasibility study in mice. Radiology 231, 659-666.
14. Wirenfeldt M, Babcock AA, Ladeby R, Lambertsen KL, Dagnaes-Hansen F, Leslie RG, Owens T, and Finsen B (2005). Reactive microgliosis engages distinct responses by microglial subpopulations after minor central nervous system injury. J Neurosci Res 82, 507-514.
15. Moore A, Marecos E, Bogdanov A Jr, and Weissleder R (2000). Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 214, 568-574.
16. Shah K, Bureau E, Kim DE, Yang K, Tang Y, Weissleder R, and Breakefield XO (2005). Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann Neurol 57, 34-41.
17. Barth RF (1998). Rat brain tumor models in experimental neurooncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neuro-Oncol 36, 91-102.
18. Zimmer C, Weissleder R, Poss K, Bogdanova A, Wright SC Jr, and Enochs WS (1995). MR imaging of phagocytosis in experimental gliomas. Radiology 197, 533-538.
19. Zimmer C, Wright SC Jr, Engelhardt RT, Johnson GA, Kramm C, Breakefield XO, and Weissleder R (1997). Tumor cell endocytosis imaging facilitates delineation of the glioma-brain interface. Exp Neurol 143, 61-69.
20. Fleige G, Nolte C, Synowitz M, Seeberger F, Kettenmann H, and Zimmer C (2001). Magnetic labeling of activated microglia in experimental gliomas. Neoplasia 3, 489-499.
21. Enochs WS, Harsh G, Hochberg F, and Weissleder R (1999). Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging 9, 228-232.
22. Neuwelt EA, Varallyay P, Bago AG, Muldoon LL, Nesbit G, and Nixon R (2004). Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathol Appl Neurobiol 30, 456-471.
23. Streit WJ (2000). Microglial response to brain injury: a brief synopsis. Toxicol Pathol 28, 28-30.
24. Streit WJ and Kincaid-Colton CA (1995). The brain's immune system. Sci Am 273, 54-55, 58-61.
25. Roggendorf W, Strupp S, and Paulus W (1996). Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol (Berl) 92, 288-293.
26. Badie B and Schartner JM (2000). Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Neurosurgery 46, 957-961 (discussion 961-952).
27. Morioka T, Baba T, Black KL, and Streit WJ (1992). Response of microglial cells to experimental rat glioma. Glia 6, 75-79.
28. Morioka T, Baba T, Black KL, and Streit WJ (1992). Immunophenotypic analysis of infiltrating leukocytes and microglia in an experimental rat glioma. Acta Neuropathol (Berl) 83, 590-597.
29. Fillmore HL, Shurm J, Furqueron P, Prabhu SS, Gillies GT, and Broaddus WC (1999). An in vivo rat model for visualizing glioma tumor cell invasion using stable persistent expression of the green fluorescent protein. Cancer Lett 141, 9-19.
30. Mourad PD, Farrell L, Stamps LD, Santiago P, Fillmore HL, Broaddus WC, and Silbergeld DL (2003). Quantitative assessment of glioblastoma invasion in vivo. Cancer Lett 192, 97-107.
31. Chicoine MR and Silbergeld DL (1995). Invading C6 glioma cells maintaining tumorigenicity. J Neurosurg 83, 665-671.
32. Grobben B, De Deyn PP, and Slegers H (2002). Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 310, 257-270.
33. Kobayashi N, Allen N, Clendenon NR, and Ko LW (1980). An improved rat brain-tumor model. J Neurosurg 53, 808-815.
34. Nimsky C, Ganslandt O, Von Keller B, Romstock J, and Fahlbusch R (2004). Intraoperative high-field-strength MR imaging: implementation and experience in 200 patients. Radiology 233, 67-78.
35. Fenchel S, Boll DT, and Lewin JS (2003). Intraoperative MR imaging. Magn Reson Imaging Clin North Am 11, 431-447.
36. Renner C, Lindner D, Schneider JP, and Meixensberger J (2005). Evaluation of intra-operative ultrasound imaging in brain tumor resection: a prospective study. Neurol Res 27, 351-357.
37. Unsgaard G, Ommedal S, Muller T, Gronningsaeter A, and Nagelhus Hernes TA (2002). Neuronavigation by intraoperative three-dimensional ultrasound: initial experience during brain tumor resection. Neurosurgery 50, 804-812 (discussion 812).
38. Stummer W, Reulen HJ, Novotny A, Stepp H, and Tonn JC (2003). Fluorescence-guided resections of malignant gliomas - an overview. Acta Neurochir Suppl 88, 9-12.
39. Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, Goetz AE, Kiefmann R, and Reulen HJ (1998). Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 42, 518-525 (discussion 525-516).
40. Kabuto M, Kubota T, Kobayashi H, Nakagawa T, Ishii H, Takeuchi H, Kitai R, and Kodera T (1997). Experimental and clinical study of detection of glioma at surgery using fluorescent imaging by a surgical microscope after fluorescein administration. Neurol Res 19, 9-16.
41. Kremer P, Wunder A, Sinn H, Haase T, Rheinwald M, Zillmann U, Albert FK, and Kunze S (2000). Laser-induced fluorescence detection of malignant gliomas using fluorescein-labeled serum albumin: experimental and preliminary clinical results. Neurol Res 22, 481-489.